Ganik Sakitri, Undari Nurkalis

Electrical Stimultan sebagai Upaya Menurunkan Kadar Gula Darah Pasien Diabetes Mellitus Tipe II di Puskesmas Stabelan

Introduction

Electrical stimultan sebagai upaya menurunkan kadar gula darah pasien diabetes mellitus tipe ii di puskesmas stabelan. Pelajari efektivitas stimulan elektrik dalam menurunkan kadar gula darah pasien Diabetes Mellitus Tipe II. Penelitian di Puskesmas Stabelan menunjukkan penurunan signifikan. Terapi non-farmakologis menjanjikan.

Abstract

The non-communicable disease that is the biggest cause of death is diabetes mellitus. One of the non-pharmacological therapies for diabetes sufferers is the use of electrical stimulants. The application of electrical stimulants to diabetes mellitus patients was carried out at the Stabelan Health Center with a One Group pretest posttest design. Samples were taken using purposive sampling techniques with 20 respondents. Research results There is a very strong correlation between GDS values before and after intervention, with a correlation coefficient of 0.993 and a probability value of 0.000. This strong correlation indicates a consistent relationship between the two measurements. These results can be interpreted that there is a difference in blood sugar levels before and after being given Electrical stimulants in diabetes mellitus patients at the Stabelan Health Center in Surakarta. The conclusion of this study is that there is a statistically significant difference between the average blood sugar levels before and after being given electrical stimulants

Review

This study investigates the potential of electrical stimulation as a non-pharmacological intervention to lower blood glucose levels in Type II Diabetes Mellitus patients, a highly relevant area given the global burden of the disease. The abstract clearly states the objective and reports a statistically significant reduction in blood sugar levels following the intervention, as evidenced by a p-value of 0.000. The application of this therapy in a primary healthcare setting, such as the Stabelan Health Center, highlights a practical approach to managing diabetes within a community context, making the findings of potential interest for public health initiatives. However, the methodological design presents significant limitations that prevent drawing strong causal conclusions. The "One Group pretest posttest design" inherently lacks a control group, making it impossible to attribute the observed changes solely to the electrical stimulation. Factors such as natural fluctuations in blood sugar, lifestyle changes during the study period, or the Hawthorne effect could all contribute to the reduction. Furthermore, the abstract mentions a "very strong correlation between GDS values before and after intervention, with a correlation coefficient of 0.993." While a strong correlation between pre and post measurements might suggest consistency, it is not the primary metric for assessing the *effect* of an intervention; rather, the *change* in mean values is. This high correlation also raises questions about data variance or specific characteristics of the dataset that warrant further explanation. The reliance on GDS (Random Blood Sugar) as the sole outcome measure is also less robust than including fasting blood sugar or HbA1c. To strengthen future research in this promising area, several recommendations are pertinent. A randomized controlled trial (RCT) incorporating a sham stimulation or a standard care control group would be essential to establish causality and mitigate confounding factors. A larger sample size would also improve the generalizability of the findings. Crucially, the abstract lacks specific details regarding the electrical stimulation protocol, such as the type of current, intensity, frequency, duration, and site of application, which are vital for replication and understanding the potential mechanism of action. Future studies should aim to address these methodological gaps and provide comprehensive details to build a more robust evidence base for electrical stimulation as a therapeutic option for diabetes management.

Full Text

Comments

You need to be logged in to post a comment.